Skip to main content

Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding. 

Refine your results

Filters
Search
Include spaces in matter number if applicable. Ex.: 182 3125
Date
Displaying 4061 - 4080 of 5969
Cases and Proceedings

Allergan, Inc., and Inamed Corporation, In the Matter of

The consent order requires that Allergan and Inamed divest the rights to develop and distribute Reloxin, a potential Botox rival, to settle charges that Allergan’s $3.2 billion purchase of Inamed would reduce competition and force consumers to pay higher prices for botulinum toxin type A products. Under the terms of the FTC settlement, the companies will return the development and distribution rights to Reloxin to Ipsen Ltd., its U.K.- based manufacturer.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
061 0031
Docket Number
C-4156
Cases and Proceedings

Health Care Alliance of Laredo, L.C., In the Matter of

A physicians’ independent practice association in Texas agreed to settle charges that it engaged in unlawful collective bargaining to set fees its members would accept from health insurance plans and advised its members against dealing individually with plans. The Commission charged that both practices resulted in higher medical costs for consumers. The consent order settling the FTC’s charges will prohibit the IPA from engaging in such anticompetitive conduct in the future.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410097
Cases and Proceedings

Teva Pharmaceutical Industries Ltd. and IVAX Corporation, In the Matter of

The consent order allowed Teva to acquire IVAX Corporation, provided the companies sell the rights and assets needed to manufacture and market 15 generic pharmaceutical products. Among the drugs sold were several forms of generic amoxicillin and amoxicillin clavulanate potassium that are widely used in the United States.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
051 0214
Docket Number
C-4155
Cases and Proceedings
Commissioner Statements

Statement of Commissioner Jon Leibowitz and Commissioner Harbour Concerning the Closing of the Investigation into Transactions Involving Comcast, Time Warner Cable and Adelphia Communications

Date
By
Jon Leibowitz, Former Chairman;
Pamela Jones Harbour, Former Commissioner
Cases and Proceedings
Commissioner Statements

Statement of Chairman Majoras, Commissioner Kovacic, and Commissioner Rosch concerning the closing of the investigation into Transactions Involving Comcast, Time Warner Cable and Adelphia Communications

Date
By
Deborah Platt Majoras, Former Chairman;
William Kovacic, Former Chairman;
J. Thomas Rosch, Former Commissioner
Cases and Proceedings
Petitions to Quash

ExxonMobil

Date
Matter Number
051 0243
Displaying 4061 - 4080 of 5969
Return to top